Clinical Trial Update: Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial of Nimotuzumab with radiotherapy in pediatric diffuse intrinsic brainstem gliomas has completed, and results from this study are reported. The upd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Brainstem Gliomas

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Diffuse Intrinsic Brainstem Gliomas | Phase 2 | Status: COMPLETED